First DuoCap probiotic launches in South Africa.
The first probiotic in South Africa to utilise DuoCap technology – ProbitecTM – was launched this month (October 2020) by Simondium-based pharmaceutical company, Evexia Pharma.
Dual-cap technology revolutionised ingestible medication and supplement markets worldwide because it dramatically increased the efficacy of these products by protecting the active ingredients from stomach acid until they reach the lower intestine, where they are most readily absorbed.
Lactobacillus acidophilus, the probiotic strain used by Probitec, is clinically proven to reduce the symptoms caused by the effects of antibiotics, lactose Intolerance, diarrhoea, IBS, candida, allergies and bacterial vaginosis.
In addition, supplementing your diet with a probiotic to build a healthy gut has numerous benefits including better overall health, a boosted immune system, elevated mood, more energy, improved digestion and absorption of medicine, supplements and food, and regular bowel movements.
However, most probiotics don’t even make it to the gut. If these good bacteria are not protected, as much as 90% are destroyed by stomach acid.
By contrast, Probitec’s DuoCap™ technology ensures the full CFU1 count of probiotic bacteria is delivered to the lower intestine. According to analyses of the best-selling probiotics, ProbitecTM was shown to deliver 10 times more probiotics to the gut than the next best performing brand, and 2000 times more than the market leader.
“The message is clear: If you take one probiotic a day, make it Probitec™,” said Evexia Pharma director, Cameron du Toit. According to du Toit, there are two major benefits of increasing CFU delivery to the lower intestine. The first is increased efficacy of the probiotic, and the second is value for money.
“A probiotic that doesn’t get to the gut is as valuable as a dart that doesn’t hit the board – you’ve wasted a throw (your cash) and you haven’t earned any points (benefited from treatment)."
“But, because all other probiotic brands experience such a high mortality rate, and given the fact that Probitec™ delivers 10 billion CFUs of probiotic bacteria, Probitec™ is seven times more cost effectively than the next best and 25 times more than the average."
“Probitec™ brings the industry average cost per billion CFU delivered to the lower intestine down from R320 to just R1.15."
“Probitec™ also improves patient compliance. Research shows that one of the main contributors to ineffective treatment is patient noncompliance. Our unique Duocap™ delivery system means that patients can take Probitec™ and their antibiotic at the same time, increasing compliance and improving patient outcomes."
“Finally, ProbitecTM capsules are made of natural, vegan plant fibres, do not have any additives and are translucent with no toxins or colouring. They are sugar free, Solvent Free, Preservative Free, Gluten Free, GMO Free, and vegetarian and Halaal friendly,” he said.
Probitec™ uses LA-14 Lactobacillus acidophilus, a probiotic found in the human body, predominantly in the digestive and urinary system.
The recommended retail price for a month’s supply of ProbitecTM capsules is R349. They can be purchased from www.naturalchoice.co.za/collections/probitec, www.takealot.com and select Dis-Chem, Link, Alpha and MediRite pharmacies nationwide.
Follow the conversation online: